The role of notch signaling in the development of a normal B-cell repertoire

Immunology and Cell Biology

Volumn 88, Issue 2, 2010, Pages 117-124

  Cruickshank, Mark N ^a   Ulgiati, Daniela ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autoimmunity; B cell development; Differentiation; Notch

Indexed keywords

ANTIBODY; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL CYCLE; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CROSS LINKING; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MAMMAL; MOLECULE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOPOIESIS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

EID: 77149162007     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.73     Document Type: Review

References (119)

1. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005; 435: 964-968.
2. Pires-daSilva A, Sommer RJ. The evolution of signalling pathways in animal development. Nat Rev Genet 2003; 4: 39-49.
3. Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 2008; 29: 691-703.
4. Skokos D, Nussenzweig MC. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J ExpMed 2007; 204: 1525-1531.
5. Nakano N, Nishiyama C, Yagita H, Koyanagi A, Akiba H, Chiba S et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol 2009; 123: 74-81 e71.
6. Sakata-Yanagimoto M, Nakagami-Yamaguchi E, Saito T, Kumano K, Yasutomo K, Ogawa S et al. Coordinated regulation of transcription factors through Notch2 is an important mediator of mast cell fate. Proc Natl Acad Sci USA 2008; 105: 7839-7844.
7. Radke AL, Reynolds LE, Melo RC, Dvorak AM, Weller PF, Spencer LA. Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation. Blood 2009; 113: 3092-3101.
8. Kijima M, Yamaguchi T, Ishifune C, Maekawa Y, Koyanagi A, Yagita H et al. Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci USA 2008; 105: 7010-7015.
9. Tanigaki K, Honjo T. Regulation of lymphocyte development by Notch signaling. Nat Immunol 2007; 8: 451-456.
10. Rothenberg EV. Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals. Immunity 2007; 26: 690-702.
11. Laky K, Fleischacker C, Fowlkes BJ. TCR and Notch signaling in CD4 and CD8 T-cell development. Immunol Rev 2006; 209: 274-283.
12. Laky K, Fowlkes BJ. Notch signaling in CD4 and CD8 T cell development. Curr Opin Immunol 2008; 20: 197-202.
13. Rothenberg EV, Moore JE, Yui MA. Launching the T-cell-lineage developmental programme. Nat Rev Immunol 2008; 8: 9-21.
14. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008; 20: 149-157.
15. Carey JB, Moffatt-Blue CS, Watson LC, Gavin AL, Feeney AJ. Repertoire-based selection into the marginal zone compartment during B cell development. J Exp Med 2008; 205: 2043-2052.
16. Esplin BL, Welner RS, Zhang Q, Borghesi LA, Kincade PW. A differentiation pathway for B1 cells in adult bone marrow. Proc Natl Acad Sci USA 2009; 106: 5773-5778.
17. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998; 393: 382-386.
18. Barolo S, Walker RG, Polyanovsky AD, Freschi G, Keil T, Posakony JW. A notchindependent activity of suppressor of hairless is required for normal mechanoreceptor physiology. Cell 2000; 103: 957-969.
19. Song LL, Peng Y, Yun J, Rizzo P, Chaturvedi V, Weijzen S et al.Notch-1 associates with IKK alpha and regulates IKK activity in cervical cancer cells. Oncogene 2008; 27: 5833-5844.
20. Lam LT, Ronchini C, Norton J, Capobianco AJ, Bresnick EH. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1. J Biol Chem 2000; 275: 19676-19684.
21. Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nat Immunol 2004; 5: 247-253.
22. Dallas MH, Varnum-Finney B, Delaney C, Kato K, Bernstein ID. Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells. J Exp Med 2005; 201: 1361-1366.
23. de La Coste A, Freitas AA. Notch signaling: distinct ligands induce specific signals during lymphocyte development and maturation. Immunol Lett 2006; 102: 1-9.
24. Haltiwanger RS. Regulation of signal transduction pathways in development by glycosylation. Curr Opin Struct Biol 2002; 12: 593-598.
25. Stanley P, Guidos CJ. Regulation of Notch signaling during T- and B-cell development by O-fucose glycans. Immunol Rev 2009; 230: 201-215.
26. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000; 228: 151-165.
27. Izon DJ, Aster JC, He Y, Weng A, Karnell FG, Patriub V et al. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 2002; 16: 231-243.
28. Matsuno K, Eastman D, Mitsiades T, Quinn AM, Carcanciu ML, Ordentlich P et al. Human deltex is a conserved regulator of Notch signalling. Nat Genet 1998; 19: 74-78.
29. Pajerowski AG, Nguyen C, Aghajanian H, Shapiro MJ, Shapiro VS. NKAP is a transcriptional repressor of notch signaling and is required for T cell development. Immunity 2009; 30: 696-707.
30. Fischer A, Gessler M. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007; 35: 4583-4596.
31. Ohsawa R, Ohtsuka T, Kageyama R. Mash1 and Math3 are required for development of branchiomotor neurons and maintenance of neural progenitors. J Neurosci 2005; 25: 5857-5865.
32. Sakamoto M, Hirata H, Ohtsuka T, Bessho Y, Kageyama R. The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. J Biol Chem 2003; 278: 44808-44815.
33. Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006; 25: 129-138.
34. Nie L, Perry SS, Zhao Y, Huang J, Kincade PW, Farrar MA et al. Regulation of lymphocyte development by cell-type-specific interpretation of Notch signals. Mol Cell Biol 2008; 28: 2078-2090.
35. Michie AM, Chan AC, Ciofani M, Carleton M, Lefebvre JM, He Y et al. Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals. Int Immunol 2007; 19: 1421-1430.
36. Alt FW, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M et al. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J 1984; 3: 1209-1219.
37. ten Boekel E, Melchers F, Rolink A. The status of Ig loci rearrangements in single cells from different stages of B cell development. Int Immunol 1995; 7: 1013-1019.
38. Pillai S, Baltimore D. Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain. Nature 1987; 329: 172-174.
39. Tsubata T, Reth M. The products of pre-B cell-specific genes (lambda 5 and VpreB) and the immunoglobulin mu chain form a complex that is transported onto the cell surface. J Exp Med 1990; 172: 973-976.
40. Yamamoto M, Hayashi K, Nojima T, Matsuzaki Y, Kawano Y, Karasuyama H et al. BASH-novel PKC-Raf-1 pathway of pre-BCR signaling induces {kappa} gene rearrangement. Blood 2006; 108: 2703-2711.
41. Gauld SB, Dal Porto JM, Cambier JC. B cell antigen receptor signaling: roles in cell development and disease. Science 2002; 296: 1641-1642.
42. Meffre E, Casellas R, Nussenzweig MC. Antibody regulation of B cell development. Nat Immunol 2000; 1: 379-385.
43. Levine MH, Haberman AM, Sant'Angelo DB, Hannum LG, Cancro MP, Janeway Jr CA et al. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc Natl Acad Sci USA 2000; 97: 2743-2748.
44. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-1377.
45. Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 2006; 203: 393-400.
46. McHeyzer-Williams MG. B cells as effectors. Curr Opin Immunol 2003; 15: 354-361.
47. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg LA. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999; 96: 2250-2255.
48. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005; 26: 347-362.
49. Montecino-Rodriguez E, Dorshkind K. New perspectives in B-1 B cell development and function. Trends Immunol 2006; 27: 428-433.
50. Song H, Cerny J. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 2003; 198: 1923-1935.
51. Srivastava B, Lindsley RC, Nikbakht N, Allman D. Models for peripheral B cell development and homeostasis. Semin Immunol 2005; 17: 175-182.
52. Srivastava B, Quinn III WJ, Hazard K, Erikson J, Allman D. Characterization of marginal zone B cell precursors. J Exp Med 2005; 202: 1225-1234.
53. Thomas MD, Srivastava B, Allman D. Regulation of peripheral B cell maturation. Cell Immunol 2006; 239: 92-102.
54. Tung JW, Mrazek MD, Yang Y, Herzenberg LA, Herzenberg LA. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci USA 2006; 103: 6293-6298.
55. Dal Porto JM, Burke K, Cambier JC. Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck. Immunity 2004; 21: 443-453.
56. Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 2006; 18: 547-555.
57. Kawahara T, Ohdan H, Zhao G, Yang YG, Sykes M. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol 2003; 171: 5406-5414.
58. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005; 23: 7-18.
59. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14: 617-629.
60. Herzenberg LA, Tung JW. B cell lineages: documented at last. Nat Immunol 2006; 7: 225-226.
61. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390-4398.
62. Harman BC, Jenkinson WE, Parnell SM, Rossi SW, Jenkinson EJ, Anderson G. T/B lineage choice occurs prior to intrathymic Notch signaling. Blood 2005; 106: 886-892.
63. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11: 299-308.
64. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004; 117: 515-526.
65. Eagar TN, Tang Q, Wolfe M, He Y, Pear WS, Bluestone JA. Notch 1 signaling regulates peripheral T cell activation. Immunity 2004; 20: 407-415.
66. Garbe AI, Krueger A, Gounari F, Zuniga-Pflucker JC, von Boehmer H. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med 2006; 203: 1579-1590.
67. Lehar SM, Dooley J, Farr AG, Bevan MJ. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 2005; 105: 1440-1447.
68. Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, Aster JC et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 2005; 6: 663-670.
69. Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker JC. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004; 200: 469-479.
70. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, Inoue H et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 2004; 20: 611-622.
71. Souabni A, Cobaleda C, Schebesta M, Busslinger M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 2002; 17: 781-793.
72. Maeda T, Merghoub T, Hobbs RM, Dong L, Maeda M, Zakrzewski J et al. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 2007; 316: 860-866.
73. Bertrand FE, Eckfeldt CE, Lysholm AS, LeBien TW. Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells. Leukemia 2000; 14: 2095-2102.
74. Saito T, Chiba S, Ichikawa M, Kunisato A, Asai T, Shimizu K et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003; 18: 675-685.
75. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006; 6: 93-106.
76. Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood 2007; 109: 507-515.
77. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004; 20: 707-718.
78. Tanigaki K, Han H, Yamamoto N, Tashiro K, Ikegawa M, Kuroda K et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol 2002; 3: 443-450.
79. Kuroda K, Han H, Tani S, Tanigaki K, Tun T, Furukawa T et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 2003; 18: 301-312.
80. Hozumi K, Negishi N, Suzuki D, Abe N, Sotomaru Y, Tamaoki N et al. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat Immunol 2004; 5: 638-644.
81. Tan JB, Xu K, Cretegny K, Visan I, Yuan JS, Egan SE et al. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity 2009; 30: 254-263.
82. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000; 12: 39-49.
83. Pillai S, Cariappa A, Moran ST. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004; 197: 206-218.
84. Wen L, Brill-Dashoff J, Shinton SA, Asano M, Hardy RR, Hayakawa K. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005; 23: 297-308.
85. Scheikl T, Reis B, Pfeffer K, Holzmann B, Beer S. Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice. Mol Immunol 2009; 46: 969-977.
86. Maillard I, Fang T, Pear WS. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005; 23: 945-974.
87. de Andrés B, Cortegano I, Serrano N, del Rio B, Martín P, Gonzalo P et al. A population of CD19highCD45R-/lowCD21low B lymphocytes poised for spontaneous secretion of IgG and IgA antibodies. J Immunol 2007; 179: 5326-5334.
88. Hardy RR, Hayakawa K. A developmental switch in B lymphopoiesis. Proc Natl Acad Sci USA 1991; 88: 11550-11554.
89. de Andrés B, Gonzalo P, Minguet S, Martínez-Marin JA, Soro PG, Marcos MA et al. The first 3 days of B-cell development in the mouse embryo. Blood 2002; 100: 4074-4081.
90. Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985; 161: 1554-1568.
91. Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci USA 1995; 92: 3348-3352.
92. Haughton G, Arnold LW, Whitmore AC, Clarke SH. B-1 cells are made, not born. Immunol Today 1993; 14: 84-87; discussion 87-91.
93. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol 2006; 7: 293-301.
94. Witt CM, Hurez V, Swindle CS, Hamada Y, Klug CA. Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells. Mol Cell Biol 2003; 23: 8637-8650.
95. Witt CM, Won WJ, Hurez V, Klug CA. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol 2003; 171: 2783-2788.
96. Thomas M, Calamito M, Srivastava B, Maillard I, Pear WS, Allman D. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood 2007; 109: 3342-3350.
97. Santos MA, Sarmento LM, Rebelo M, Doce AA, Maillard I, Dumortier A et al. Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibodysecreting cells. Proc Natl Acad Sci USA 2007; 104: 15454-15459.
98. Yoon SO, Zhang X, Berner P, Blom B, Choi YS. Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis. J Immunol 2009; 183: 352-358.
99. Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006; 18: 290-296.
100. Meyer-Hermann M, Figge MT, Toellner KM. Germinal centres seen through the mathematical eye: B-cell models on the catwalk. Trends Immunol 2009; 30: 157-164.
101. Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001; 14: 603-615.
102. Hase H, Kanno Y, Kojima M, Hasegawa K, Sakurai D, Kojima H et al. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 2004; 103: 2257-2265.
103. Rhee KJ, Jasper PJ, Sethupathi P, Shanmugam M, Lanning D, Knight KL. Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues. J Exp Med 2005; 201: 55-62.
104. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999; 190: 75-89.
105. Monroe JG, Allman D. Keeping track of pro-B cells: a new model for the effects of IL-7 during B cell development. Eur J Immunol 2004; 34: 2642-2646.
106. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004; 117: 787-800.
107. Tolar P, Sohn HW, Pierce SK. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol 2005; 6: 1168-1176.
108. Diamant E, Keren Z, Melamed D. CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 2005; 105: 3247-3254.
109. Wang Y, Carter RH. CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 2005; 22: 749-761.
110. Purohit SJ, Stephan RP, Kim HG, Herrin BR, Gartland L, Klug CA. Determination of lymphoid cell fate is dependent on the expression status of the IL-7 receptor. EMBO J 2003; 22: 5511-5521.
111. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100: 4537-4543.
112. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192: 1453-1466.
113. Chiaramonte R. Still puzzling Notch signaling in B-cell malignancies. Leuk Res 2006; 30: 1331-1332.
114. Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 2005; 106: 3898-3906.
115. Hubmann R, Schwarzmeier JD, Shehata M, Hilgarth M, Duechler M, Dettke M et al. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood 2002; 99: 3742-3747.
116. Teachey DT, Seif AE, Brown VI, Bruno M, Bunte RM, Chang YJ et al. Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood 2008; 111: 705-714.
117. Lewis HD, Leveridge M, Strack PR, Haldon CD, O'neil J, Kim H et al. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol 2007; 14: 209-219.
118. Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111: 2220-2229.
119. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 2003; 22: 6598-6608.